DENTSPLY SIRONA (NASDAQ:XRAY) PT Lowered to $34.00 at Needham & Company LLC

DENTSPLY SIRONA (NASDAQ:XRAY) had its price target decreased by Needham & Company LLC from $36.00 to $34.00 in a research note published on Wednesday, Benzinga reports. Needham & Company LLC currently has a buy rating on the medical instruments supplier’s stock.

A number of other analysts have also recently weighed in on the stock. Piper Sandler reaffirmed a neutral rating and set a $32.00 target price (down previously from $35.00) on shares of DENTSPLY SIRONA in a research note on Friday, May 3rd. Stifel Nicolaus reduced their price objective on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a hold rating on the stock in a research note on Thursday, July 18th. Robert W. Baird reduced their price objective on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a neutral rating on the stock in a research note on Monday, July 22nd. The Goldman Sachs Group reduced their price objective on shares of DENTSPLY SIRONA from $34.00 to $30.00 and set a neutral rating on the stock in a research note on Monday, May 6th. Finally, Barrington Research reissued an outperform rating and issued a $38.00 price objective on shares of DENTSPLY SIRONA in a research note on Monday, July 8th. Five research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of Moderate Buy and a consensus price target of $33.44.

DENTSPLY SIRONA Trading Down 4.6 %

DENTSPLY SIRONA stock opened at $25.49 on Wednesday. DENTSPLY SIRONA has a 52 week low of $23.94 and a 52 week high of $40.92. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.97 and a current ratio of 1.33. The stock has a market capitalization of $5.17 billion, a P/E ratio of -57.93, a PEG ratio of 1.28 and a beta of 1.01. The stock has a 50-day simple moving average of $26.18 and a 200 day simple moving average of $30.08.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 EPS for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). The business had revenue of $984.00 million for the quarter, compared to the consensus estimate of $993.61 million. DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The company’s revenue for the quarter was down 4.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.51 EPS. Analysts expect that DENTSPLY SIRONA will post 1.99 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 11th. Investors of record on Friday, September 27th will be issued a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 2.51%. The ex-dividend date of this dividend is Friday, September 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -145.45%.

Insider Buying and Selling

In other news, Director Gregory T. Lucier bought 3,577 shares of the stock in a transaction on Friday, May 31st. The shares were acquired at an average cost of $27.95 per share, for a total transaction of $99,977.15. Following the purchase, the director now directly owns 58,374 shares of the company’s stock, valued at approximately $1,631,553.30. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.52% of the stock is owned by insiders.

Institutional Trading of DENTSPLY SIRONA

Several institutional investors and hedge funds have recently bought and sold shares of XRAY. Principal Securities Inc. purchased a new stake in DENTSPLY SIRONA in the 4th quarter worth approximately $26,000. Headlands Technologies LLC purchased a new stake in DENTSPLY SIRONA in the 4th quarter worth approximately $30,000. LRI Investments LLC raised its position in shares of DENTSPLY SIRONA by 82.7% during the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after buying an additional 564 shares in the last quarter. Rothschild Investment LLC purchased a new stake in shares of DENTSPLY SIRONA during the 2nd quarter valued at $32,000. Finally, Parkside Financial Bank & Trust raised its position in shares of DENTSPLY SIRONA by 33.3% during the 4th quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock valued at $42,000 after buying an additional 292 shares in the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.